E7070, a novel sulphonamide agent with potent antitumour activity in vitro and in vivo
- 1 January 2001
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 37 (17) , 2275-2282
- https://doi.org/10.1016/s0959-8049(01)00275-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Novel sulphonamide derivatives for the treatment of cancerExpert Opinion on Therapeutic Patents, 2000
- Increased LRP mRNA expression is associated with the MDR phenotype in intrinsically resistant human cancer cell linesInternational Journal of Cancer, 1997
- Cancer Cell CyclesScience, 1996
- G1 phase progression: Cycling on cueCell, 1994
- Novel sulfonamides as potential, systemically active antitumor agentsJournal of Medicinal Chemistry, 1992
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI Journal of the National Cancer Institute, 1990
- Display and Analysis of Patterns of Differential Activity of Drugs Against Human Tumor Cell Lines: Development of Mean Graph and COMPARE AlgorithmJNCI Journal of the National Cancer Institute, 1989
- Inhibition of c-myc gene expression in murine lymphoblastoma cells by geldanamycin and herbimycin, antibiotics of benzoquinoid ansamycin group.The Journal of Antibiotics, 1989
- Biological characterization and oncogene expression in human colorectal carcinoma cell linesInternational Journal of Cancer, 1988
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983